MicrobiotiX Finalizes KRW 20 Billion Series B, Securing Korea’s First Bacteriophage Clinical Trial

MicrobiotiX Finalizes KRW 20 Billion Series B, Securing Korea’s First Bacteriophage Clinical Trial – NEWSnet – News… as it used to be